NAYA Biosciences, Inc. (NAYA) Research

INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.

Market snapshot

Symbol
NAYA
Price
$2.20
Day change
+8.37%
Market cap
$1.5M
P/E ratio
-0.03x
52-week range
1.38-17.04
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Avinger, Inc. (AVGR)
  • Accelerate Diagnostics, Inc. (AXDX)
  • CareMax, Inc. (CMAX)
  • Cutera, Inc. (CUTR)
  • NeuBase Therapeutics, Inc. (NBSE)
  • OncoSec Medical Incorporated (ONCSQ)
  • Oncternal Therapeutics, Inc. (ONCT)
  • Cassava Sciences, Inc. Warrant (SAVAW)

Open NAYA Biosciences, Inc. (NAYA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.